Involving members of the public in designing and running clinical trials is very important. Not only does it help us ensure the best interests of patients are always at the forefront of researchers’ minds, but it provides valuable insights into patients’ experiences that help to shape our research.
Our Trial Management Group benefits greatly from patient representation with the involvement of Tom Haswell. Similarly, Mat Baker brings the patient perspective to our Trial Steering Committee. Watch this space for more information about how you can be involved in the National Lung Matrix Trial like Tom.